Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy
  • ‘Beyond Medical Necessity’ Hospital Stays
  • Trump’s Eli Lilly Stock Purchases
  • Changes Coming to ACA Exchanges
  • Texas ‘Detransition Clinic’

WHAT'S NEW

  • Vaccine Policy
  • 'Beyond Medical Necessity' Hospital Stays
  • Trump's Eli Lilly Stock Purchases
  • Changes Coming to ACA Exchanges
  • Texas 'Detransition Clinic'

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Mar 22 2024

Full Issue

Surgeons Achieve First Pig Kidney Transplant Into Live Patient

The groundbreaking xenotransplant happened in Boston and the organ was from a genetically modified pig: so far signs are said to be "promising." Earlier successful pig kidney transplant trials involved brain-dead human patients.

The New York Times: Surgeons Transplant Pig Kidney Into A Patient, A Medical Milestone 

Surgeons in Boston have transplanted a kidney from a genetically engineered pig into an ailing 62-year-old man, the first procedure of its kind. If successful, the breakthrough offers hope to hundreds of thousands of Americans whose kidneys have failed. So far, the signs are promising. (Rabin, 3/21)

The Wall Street Journal: New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding 

A new class of anticoagulant drugs on the horizon is taking fresh aim at one of cardiology’s toughest challenges: how to prevent blood clots that cause heart attacks and strokes, without leaving patients at risk of bleeding. At least a half-dozen experimental blood thinners are in development that inhibit a protein called factor XI, one of several blood factors that regulate how the body forms clots. (Winslow, 3/21)

The Denver Post: Knees Stiff With Arthritis? This Company Is Studying Whether Fat Injections Can Improve Motion 

A Louisville company is studying whether cells taken from patients’ fat could reduce knee pain and improve motion in people with arthritis. GID BIO is conducting a phase 3 trial of a process that extracts fat from the patient, uses a chemical reaction to isolate cells believed to have regenerative properties and injects them into the patient’s knee. (Wingerter, 3/21)

The New York Times: Toddlers Smell Like Flowers, Teens Smell ‘Goatlike,’ Study Finds

Few parents would describe the smells emanating from their adolescent children as redolent of sandalwood. But one of the distinct components of teenage body odor is a compound that evokes that warm, woody fragrance, according to a small new study, which compared the scents of adolescents to those of infants and toddlers. Unfortunately, that’s just about where the good news ended for teenagers (and their parents). Although there were many similarities between the chemicals wafting from teens and tots, the differences tended to favor the younger children, whose body odor samples had higher levels of a compound with a flowery fragrance. Adolescents, on the other hand, produced a compound that smelled like sweat and urine and had higher levels of substances described as smelling cheesy, musty and “goatlike.” (Anthes, 3/21)

Also —

Chicago Tribune: Breast Cancer Test May Make Bad Chemotherapy Recommendations For Black Patients, UIC Study Shows 

While the rest of the world was in the throes of the pandemic, Valletta Howard was wrapping her mind around a breast cancer diagnosis. (Rockett, 3/22)

Fox News: Artificial Intelligence Helps Predict Seniors’ Long-Term Care Needs: ‘Critical Next Steps’

Could artificial intelligence predict when your aging loved one will need long-term care? Approximately 70% of adults aged 65 years and older will require long-term care at some point in their lifetime, statistics show — and the time leading up to that can be fraught with uncertainty. One California company is looking to change that with its new AI platform called Waterlily. The founder and CEO, Lily Vittayarukskul, started the platform after her own personal struggles with family caregiving. (Rudy, 3/21)

Modern Healthcare: Digital Diabetes Tools Not Effective: Peterson Health Tech Study 

Most digital diabetes management tools are not cost effective and few demonstrate clinically relevant outcomes for patients, according to a study published Thursday. The results, published by the nonprofit research firm Peterson Health Technology Institute, should only increase the headwinds facing digital health companies attempting to convince payers and providers their products lead to healthier patients and lower costs. (Turner, 3/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, May 18
  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF